Clinical Trials Logo
  1. Home
  2. Analgesia
  3. NCT06230575
  4. Details
NCT06230575 Clinical Trial

Locoregional Blocks for Breast Cancer Surgeries

Analgesia Clinical Trial

Official title:
Locoregional Blocks for Breast Cancer Surgeries

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT06230575
Other study ID # AP2312-301-072
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 1, 2024
Est. completion date July 25, 2025

Study information
Verified date February 2024
Source National Cancer Institute, Egypt
Contact Walaa Y Elsabeeny, MD
Phone +201007798466
Email Walaa.elsabeeny@nci.cu.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Breast surgeries are common operative procedures that require appropriate postoperative analgesia.

Description:

Numerous pain relief techniques, including several new regional anesthesia techniques, are available for control of acute pain after breast surgery.

Recruitment information / eligibility
Status Recruiting
Enrollment 100
Est. completion date July 25, 2025
Est. primary completion date June 15, 2025
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - female cancer breast patient - age from 18- 65 Exclusion Criteria: - coagulation defect - Patient refusal - abnormal kidney and or liver function tests

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• erector spinae block
Erector spinae plane block
• retrolaminar block
Retrolaminar block
• serratus anterior block
Serratus anterior plane block
• pectoral nerve block
Pectoral nerve block

Locations
Country Name City State
Egypt Walaa Y Elsabeeny Cairo

Sponsors (1)
Lead Sponsor Collaborator
National Cancer Institute, Egypt

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary time to receive first postoperative analgesic time to first dose of rescue opioid analgesic First 24 hours postoperatively
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05534230 - Dexmedetomidine for Pain Reduction in CABG N/A
Recruiting NCT06275698 - HONEY for the Treatment of POst-Tonsillectomy Pain N/A
Recruiting NCT04436224 - Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation Phase 4
Not yet recruiting NCT04548323 - Hypoalgesic Effects of Walking and Running Imagined
Completed NCT06054945 - Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
Completed NCT04394481 - Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery Phase 4
Completed NCT04690647 - The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement. N/A
Completed NCT05034601 - ESPB vs TPVB for Postoperative Analgesia After the Nuss Procedure N/A
Completed NCT03740815 - Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection N/A
Recruiting NCT05454202 - Assessment of the Interest of ANI in the Non-communicating Patient in Palliative Care
Recruiting NCT04554186 - Serratus Anterior Plane Block Versus Thoracic Paravertebral Block. N/A
Suspended NCT04860635 - Safety of F14 Following Total Knee Replacement Phase 2/Phase 3
Not yet recruiting NCT06393777 - Effectiveness of Pre-administered Natural Sweet-tasting Solution (Honey) for Decreasing Pain of Needle Insertion N/A
Not yet recruiting NCT04519463 - The Effect of Local Anesthesia With Lidocaine During Insertion and Removal of Nasal Packing Early Phase 1
Completed NCT02916342 - Interscalene Block Versus Combined Supraprascapular: Axillary Nerve Blocks Phase 4
Completed NCT03206554 - Local Infiltration Analgesia in Total Knee Arthroplasty Phase 2
Not yet recruiting NCT02549118 - Tenoxicam for Intrapartum Analgesia Phase 2
Not yet recruiting NCT02190760 - Comparison Between Perineural and Systemic Effect of Dexamethasone for Interscalene Brachial Plexus Block. N/A
Completed NCT01789606 - Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet Phase 3
Completed NCT01299584 - ULTIVA Post Marketing Surveillance N/A